BamSEC and AlphaSense Join Forces
Learn More

ARS Pharmaceuticals Inc. – Transcripts

NASDAQ: SPRY    
Share price (11/4/26): $3.05    
Market cap (11/4/26): $303 million
Search in Documents
Key Exhibits
External Links

Transcripts

CY 2026
Earnings Revised 08/14/26 ARS Pharmaceuticals, Inc., Q2 2026 Earnings Call, Aug 13, 2026 08/13/26
Earnings Revised 05/15/26 ARS Pharmaceuticals, Inc., Q1 2026 Earnings Call, May 15, 2026 05/15/26
Earnings Revised 03/09/26 ARS Pharmaceuticals, Inc., Q4 2025 Earnings Call, Mar 09, 2026 03/09/26
CY 2025
Earnings Revised 11/10/25 ARS Pharmaceuticals, Inc., Q3 2025 Earnings Call, Nov 10, 2025 11/10/25
Earnings Revised 08/13/25 ARS Pharmaceuticals, Inc., Q2 2025 Earnings Call, Aug 13, 2025 08/13/25
Earnings Revised 05/15/25 ARS Pharmaceuticals, Inc., Q1 2025 Earnings Call, May 14, 2025 05/14/25
Earnings Revised 03/20/25 ARS Pharmaceuticals, Inc., Q4 2024 Earnings Call, Mar 20, 2025 03/20/25
Other Revised 01/15/25 ARS Pharmaceuticals, Inc. Presents at 43rd Annual J.P. Morgan Healthcare Conference 2025, Jan-15-2025 07:30 AM 01/15/25
CY 2024
Earnings Revised 01/13/25 ARS Pharmaceuticals, Inc., Q3 2024 Earnings Call, Nov 13, 2024 11/13/24
Other Revised 08/20/24 ARS Pharmaceuticals, Inc. - Special Call 08/12/24
CY 2022
M&A Revised 06/01/23 ARS Pharmaceuticals, Inc., Silverback Therapeutics, Inc. - M&A Call 07/21/22